Platinum Investment Management’s Arcus Biosciences RCUS Stock Holding History

Platinum Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.9M	Hold	134,217	–	–	0.73%	50
2025 Q4	$3.2M	Sell	134,217 -19,566	-13%	-$399K	0.74%	52
2025 Q3	$2.09M	Hold	153,783	–	–	0.14%	66
2025 Q2	$1.25M	Hold	153,783	–	–	0.08%	70
2025 Q1	$1.21M	Hold	153,783	–	–	0.07%	68
2024 Q4	$2.29M	Hold	153,783	–	–	0.13%	58
2024 Q3	$2.35M	Hold	153,783	–	–	0.11%	63
2024 Q2	$2.34M	Sell	153,783 -50,615	-25%	-$817K	0.09%	61
2024 Q1	$3.86M	Hold	204,398	–	–	0.16%	49
2023 Q4	$3.9M	Hold	204,398	–	–	0.16%	59
2023 Q3	$3.67M	Sell	204,398 -28,214	-12%	-$567K	0.14%	57
2023 Q2	$4.72M	Hold	232,612	–	–	0.16%	57
2023 Q1	$4.24M	Buy	232,612 +77,761	+50%	+$1.49M	0.15%	61
2022 Q4	$3.2M	Buy	154,851 +93,071	+151%	+$2.56M	0.12%	65
2022 Q3	$1.62M	Hold	61,780	–	–	0.07%	84
2022 Q2	$1.57M	Hold	61,780	–	–	0.06%	91
2022 Q1	$1.95M	Hold	61,780	–	–	0.06%	85
2021 Q4	$2.5M	Hold	61,780	–	–	0.07%	88
2021 Q3	$2.15M	Sell	61,780 -13,510	-18%	-$420K	0.06%	98
2021 Q2	$2.07M	Hold	75,290	–	–	0.05%	92
2021 Q1	$2.11M	Sell	75,290 -11,768	-14%	-$410K	0.05%	86
2020 Q4	$2.26M	Hold	87,058	–	–	0.05%	88
2020 Q3	$1.49M	Hold	87,058	–	–	0.04%	91
2020 Q2	$2.15M	Sell	87,058 -16,682	-16%	-$450K	0.05%	82
2020 Q1	$1.44M	Hold	103,740	–	–	0.04%	84
2019 Q4	$1.05M	Sell	103,740 -33,153	-24%	-$279K	0.02%	85
2019 Q3	$1.25M	Sell	136,893 -9,300	-6%	-$74.7K	0.03%	78
2019 Q2	$1.16M	Hold	146,193	–	–	0.03%	81
2019 Q1	$1.83M	Hold	146,193	–	–	0.04%	69
2018 Q4	$1.57M	Buy	146,193 +50,352	+53%	+$588K	0.05%	59
2018 Q3	$1.34M	Buy	95,841 +43,000	+81%	+$548K	0.04%	65
2018 Q2	$647K	Buy	52,841 +42,841	+428%	+$672K	0.02%	81
2018 Q1	$154K	Buy	+10,000	New	+$167K	﹤0.01%	85

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Platinum Investment Management's RCUS Position: Q1 2026 in Review

Platinum Investment Management held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 134,217 shares worth $2.9M. The position accounts for 0.73% of the portfolio, ranked #50.

Platinum Investment Management first reported a position in RCUS in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.72M in Q2 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

Platinum Investment Management held 134,217 shares of Arcus Biosciences worth $2.9M as of Q1 2026.
Platinum Investment Management left its Arcus Biosciences share count unchanged in Q1 2026.
Arcus Biosciences made up 0.73% of Platinum Investment Management's portfolio in Q1 2026, its #50 holding.
Platinum Investment Management first reported a position in Arcus Biosciences in Q1 2018 and has held it in 33 quarters since.
Platinum Investment Management's Arcus Biosciences position peaked at $4.72M in Q2 2023.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.